Pizza chains are under pressure. GLP-1 use is only one part of the problem
Domino's, Papa Johns and Pizza Hut face weaker demand, more delivery competition and changing eating habits, including GLP-1 use.

TL;DR
- Big pizza chains are struggling with weaker consumer spending, more dining options, and the rise of GLP-1 medications.
- The number of U.S. pizza restaurants has decreased significantly since its peak in 2019.
- Sales at U.S. pizza restaurants, including chains and independent establishments, have fallen.
- Some major chains like Papa Johns and Pizza Hut have reported declining same-store sales, while Domino's showed modest growth.
- Competition has intensified from third-party delivery platforms and other fast-food chains.
- Rising pizza prices and the availability of cheaper alternatives like frozen pizza and convenience store offerings are impacting demand.
- Shifting consumer attitudes toward nutrition and the impact of GLP-1 drugs on appetite for high-carbohydrate and high-fat foods are also contributing factors.
- Chains are introducing new products and turnaround plans to address the downturn.